Gluten-sensitive enteropathy and functional dyspepsia;Enteropatía sensible al gluten y dispepsia funcional

Gastroenterologia y Hepatologia

Volumn 35, Issue 2, 2012, Pages 78-88

  Santolaria Piedrafita, Santos ^a   Fernández Bañares, Fernando ^b  

^a HOSPITAL SAN JORGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Duodenal biopsies; Dyspepsia; Gluten sensitive enteropathy; Lymphocytic enteropathy

Indexed keywords

ARTICLE; CELIAC DISEASE; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DUODENUM BIOPSY; DYSPEPSIA; GASTROINTESTINAL ENDOSCOPY; HUMAN; LYMPHOCYTE; MORBIDITY; MORTALITY; QUALITY OF LIFE; SYMPTOM;

ALGORITHMS; CELIAC DISEASE; DYSPEPSIA; GASTROINTESTINAL MOTILITY; HUMANS; PREVALENCE;

EID: 84856949764     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2011.10.006     Document Type: Article

References (52)

1. Manejo del paciente con dispepsia. Guía de practica clínica. Asociación Española de Gastroenterologia, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano 2012, Grupo de trabajo de la guía de práctica clínica sobre dispepsia.
2. AGA Institute. Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 2006; 131:1977-1980.
3. Diagnóstico precoz de la enfermedad celíaca 2008, Grupo de trabajo sobre diagnóstico precoz de la enfermedad celíaca, Ministerio de Sanidad y Consumo, Madrid.
4. Vivas S., Santolaria S. Enfermedad celiaca. Tratamiento de las Enfermedades Gastroenterológicas 2010, 265-278. Asociación Española de Gastroenterologia, Barcelona. 3.a ed. J. Ponce, A. Castells, F. Gomollon (Eds.).
5. Rubio-Tapia A., Rahim M.W., See J.A., Lahr B.D., Wu T.T., Murray J.A. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010, 105:1412-1420.
6. Kurppa K., Collin P., Sievanen H., Huhtala H., Maki M., Kaukinen K. Gastrointestinal symptoms, quality of life and bone mineral density in mild enteropathic coeliac disease: A prospective clinical trial. Scand J Gastroenterol 2010, 45:305-314.
7. Tack J., Talley N.J., Camilleri M., Holtmann G., Hu P., Malagelada J.R., et al. Functional gastroduodenal disorders. Gastroenterology 2006, 130:1466-1479.
8. Geeraerts B., Tack J. Functional dyspepsia: past, present, and future. J Gastroenterol 2008, 43:251-255.
9. El-Serag H.B., Talley N.J. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004, 19:643-654.
10. Talley N.J., Silverstein M.D., Agreus L., Nyren O., Sonnenberg A., Holtmann G. American Gastroenterological Association (AGA) technical review: evaluation of dyspepsia. Gastroenterology 1998, 114:582-595.
11. Fasano A., Berti I., Gerarduzzi T., Not T., Colletti R.B., Drago S., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163:286-292.
12. Marine M., Fernandez-Bañares F., Alsina M., Farre C., Cortijo M., Santaolalla R., et al. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009, 15:1331-1338.
13. Collin P., Wahab P.J., Murray J.A. Intraepithelial lymphocytes and coeliac disease. Best Pract Res Clin Gastroenterol 2005, 19:341-350.
14. Rostami K., Villanacci V. Microscopic enteritis: Novel prospect in coeliac disease clinical and immuno-histogenesis. Evolution in diagnostic and treatment strategies. Dig Liver Dis 2009, 41:245-252.
15. Esteve M., Rosinach M., Fernandez-Bañares F., Farre C., Salas A., Alsina M., et al. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis. Gut 2006, 55:1739-1745.
16. Monzon H., Forne M., Gonzalez C., Esteve M., Marti J.M., Rosinach M., et al. Mild enteropathy as a cause of iron-deficiency anaemia of previously unknown origin. Dig Liver Dis 2011.
17. Tursi A., Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 2003, 36:13-17.
18. Kurppa K., Collin P., Viljamaa M., Haimila K., Saavalainen P., Partanen J., et al. Diagnosing Mild Enteropathy Celiac Disease: A Randomized, Controlled Clinical Study. Gastroenterology 2009, 136:816-823.
19. Ensari A. Gluten-sensitive enteropathy (celiac disease): controversies in diagnosis and classification. Arch Pathol Lab Med 2010, 134:826-836.
20. Hopper A.D., Cross S.S., Sanders D.S. Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?. Endoscopy 2008, 40:219-224.
21. Mino M., Lauwers G.Y. Role of lymphocytic immunophenotyping in the diagnosis of gluten-sensitive enteropathy with preserved villous architecture. Am J Surg Pathol 2003, 27:1237-1242.
22. Tursi A., Brandimarte G., Giorgetti G.M. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003, 36:219-221.
23. Rostami K., Kerckhaert J., Tiemessen R., von Blomberg B.M., Meijer J.W., Mulder C.J. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999, 94:888-894.
24. Kaukinen K., Partanen J., Maki M., Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002, 97:695-699.
25. Kapitany A., Toth L., Tumpek J., Csipo I., Sipos E., Woolley N., et al. Diagnostic significance of HLA-DQ typing in patients with previous coeliac disease diagnosis based on histology alone. Aliment Pharmacol Ther 2006, 24:1395-1402.
26. Catassi C., Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010, 123:691-693.
27. Wahab P.J., Crusius J.B., Meijer J.W., Mulder C.J. Gluten challenge in borderline gluten-sensitive enteropathy. Am J Gastroenterol 2001, 96:1464-1469.
28. Ciacci C., Cirillo M., Sollazzo R., Savino G., Sabbatini F., Mazzacca G. Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol 1995, 30:1077-1081.
29. Zipser R.D., Patel S., Yahya K.Z., Baisch D.W., Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci 2003, 48:761-764.
30. Dickey W., Hughes D. Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol 1999, 94:2182-2186.
31. Bardella M.T., Minoli G., Ravizza D., Radaelli F., Velio P., Quatrini M., et al. Increased prevalence of celiac disease in patients with dyspepsia. Arch Intern Med 2000, 160:1489-1491.
32. Vivas S., Ruiz de Morales J.M., Martinez J., González M.C., Martín S., Martín J., et al. Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients. Eur J Gastroenterol Hepatol 2003, 15:479-483.
33. Locke G.R., Murray J.A., Zinsmeister A.R., Melton L.J., Talley N.J. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004, 79:476-482.
34. Cammarota G., Pirozzi G.A., Martino A., Zuccala G., Cianci R., Cuoco L., et al. Reliability of the " immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. Gastrointest Endosc 2004, 60:223-228.
35. Lima V.M., Gandolfi L., Pires J.A., Pratesi R. Prevalence of celiac disease in dyspeptic patients. Arq Gastroenterol 2005, 42:153-156.
36. Lecleire S., Di Fiore F., Antonietti M., Savoye G., Lemoine F., Le Pessot F., et al. Endoscopic markers of villous atrophy are not useful for the detection of celiac disease in patients with dyspeptic symptoms. Endoscopy 2006, 38:696-701.
37. Ozaslan E., Akkorlu S., Eskioglu E., Kayhan B. Prevalence of silent celiac disease in patients with dyspepsia. Dig Dis Sci 2007, 52:692-697.
38. Hadithi M., von Blomberg B.M., Crusius J.B., Bloemena E., Kostense P.J., Meijer J.W., et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007, 147:294-302.
39. Giangreco E., D'Agate C., Barbera C., Puzzo L., Aprile G., Naso P., et al. Prevalence of celiac disease in adult patients with refractory functional dyspepsia: value of routine duodenal biopsy. World J Gastroenterol 2008, 14:6948-6953.
40. Rostami-Nejad M., Villanacci V., Mashayakhi R., Molaei M., Bassotti G., Zojaji H., et al. Celiac disease and Hp infection association in Iran. Rev Esp Enferm Dig 2009, 101:850-854.
41. Ford A.C., Ching E., Moayyedi P. Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsia. Aliment Pharmacol Ther 2009, 30:28-36.
42. Santolaria S., Alcedo J., Cuartero B., Díez I., Abascal M., García Prats M., et al. Elevada prevalencia de formas leves de enteropatía sensible al gluten en pacientes con dispepsia funcional del tipo distrés postprandial. Gastroenterol Hepatol 2010, 33:2015-2016.
43. Giorgetti G.M., Tursi A., Brandimarte G., Rubino E., Gasbarrini G. Dysmotility-like dyspeptic symptoms in coeliac patients: role of gluten and Helicobacter pylori infection. Dig Liver Dis 2000, 32:73-74.
44. Tursi A. Gastrointestinal motility disturbances in celiac disease. J Clin Gastroenterol 2004, 38:642-645.
45. Rocco A., Sarnelli G., Compare D., De Colibus P., Micheli P., Somma P., et al. Tissue ghrelin level and gastric emptying rate in adult patients with celiac disease. Neurogastroenterol Motil 2008, 20:884-890.
46. Bassotti G., Villanacci V., Mazzocchi A., Mariano M., Incardona P., Clerici C., et al. Antroduodenojejunal motor activity in untreated and treated celiac disease patients. J Gastroenterol Hepatol 2008, 23:E23-E28.
47. Lee K.J., Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil 2010, 16:251-257.
48. Usai P., Usai Satta P., Lai M., Corda M.G., Piras E., Calcara C., et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest 1997, 27:1009-1015.
49. Hopman W.P., Rosenbusch G., Hectors M.P., Jansen J.B. Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease. Gut 1995, 36:17-21.
50. Wahab P.J., Hopman W.P., Jansen J.B. Basal and fat-stimulated plasma peptide YY levels in celiac disease. Dig Dis Sci 2001, 46:2504-2509.
51. Bures J., Cyrany J., Kohoutova D., Forstl M., Rejchrt S., Kvetina J., et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010, 16:2978-2990.
52. Tursi A., Brandimarte G., Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003, 98:839-843.